Navigation Links
New Option for Erasing Wrinkles
Date:6/4/2009

Dysport® cosmetic injection receives U.S. FDA Approval

(Vocus) June 4, 2009-- A new wrinkle-smoother will be arriving in doctors' offices in July: the U.S. FDA has approved the cosmetic injectable Dysport®. Dysport®, approved in the European Union, Brazil, Argentina and more than 26 countries worldwide is a form of botulinum type A, similar to the protein found in Botox® Cosmetic, approved for fighting wrinkles in the U.S. since 2004. Dysport® and Botox® are both cosmetic injections that temporarily relax the muscles in the face that create expressions, such as frown lines between the brows, that over time result in visible facial lines and deeper creases. "Although their action is similar, Dysport® and Botox® Cosmetic are two different drugs," said oculoplastic surgeon Dr. Brian Biesman, Coalition leader and Assistant Clinical Professor at Vanderbilt University Medical Center in Nashville, TN. "Both temporarily modify the action of facial muscles, smoothing out undesirable lines between the brows, across the forehead or crow's feet to restore a more youthful, less stressed appearance. But they are not interchangeable, they have distinct dosing differences."

"Cosmetic injections of any kind require examination, the informed consent process and prescription, including the proper dose, by a qualified board-certified plastic surgeon, facial plastic surgeon, oculoplastic surgeon or dermatologist, to achieve both a visually pleasing and a safe outcome. The doctor you choose should also either provide the injection or directly supervise the registered nurse (R.N) or physician's assistant (P.A.) who will inject you," said plastic surgeon and Coalition leader Mark Codner, MD, of Atlanta, GA. "In my practice, I inject all my patients personally. You have the right to request that your doctor perform the injection if you
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Conceptual Options, a Center for Surrogacy & Egg Donation, Announces Third Party Assurance Program
2. Americas Future Now Straw Poll: Progressives See Health Care Reform With Public Option As Top Priority
3. Weight-Loss Surgery Options Compared in Super-Obese
4. Study Results Show CAQH CORE Certification Dramatically Cuts Administrative Costs, Accelerates I.T. Adoption by Providers and Health Plans
5. Allscripts and SYNNEX Corporation Form Distribution Partnership to Accelerate Adoption of Electronic Health Records
6. ChemGenexs omacetaxine may provide first viable treatment option for highly resistant form of CML
7. Survey Reveals Injectable Procedures Are Mainstream And Accepted Medical Aesthetic Treatment Options
8. Valeant Grants Schering-Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal
9. CBay Announces the MTSO Partnership Program to Drive Digital Health Record Adoption
10. Caldwell Consumer Health Becomes Revive Personal Products, Inc., with OPTIONS(TM) Line of Womens Sexual Health Products & Oral Health Brands; See Us at NACDS Booth 533 (The Emerson Group)
11. Health Affairs Report On Mass. Mandatory Insurance Law Confirms: Strong Public Option Must Be Included in National Health Reform
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Option for Erasing Wrinkles
(Date:9/15/2014)... Club wear is provocative, revealing, or fetish ... with a very relaxed dress code. There are various types ... on the location of the club, the club's dress code ... and retailer, has delightedly pronounced its new series of delicate ... low prices. , A nightclub (also known as a discothèque, ...
(Date:9/15/2014)... 2014 1Heart Caregiver Services Training ... staff of Regency Park Oak Knoll during the ... Executive Director Gladys Broxton. This continuing professional education ... 1Heart Shirley Billedo and Regency Park officers of ... Jeanine Hernandez and Activities Coordinator Alfonso Escalante. , ...
(Date:9/15/2014)... BROOK, Ill. (PRWEB) September 15, 2014 ... at risk for stroke who might benefit from aggressive ... in the journal Radiology. , The study looked ... of the major blood vessels supplying blood to the ... stenosis is the primary cause of up to 20 ...
(Date:9/15/2014)... neuroscience researchers at the University of Copenhagen have ... cause Parkinson,s disease. The findings have recently been ... . , The defining symptoms of Parkinson,s ... There is currently no cure for the condition, ... with the potential to shed some light on ...
(Date:9/15/2014)... 15, 2014 Today, Zane Benefits, the ... Bank’s Speaking on Business radio show. , According ... so employers know it doesn’t make sense to choose ... also save the employer and employee as much as ... of Zions Bank's Speaking on Business , Chris ...
Breaking Medicine News(10 mins):Health News:Delicate Club Wears Are For Sale At Fecbek.com 2Health News:1Heart Caregiver Services Training Director Randolph Neil Conducted In-Service Training at Regency Park Oak Knoll Pasadena 2Health News:1Heart Caregiver Services Training Director Randolph Neil Conducted In-Service Training at Regency Park Oak Knoll Pasadena 3Health News:1Heart Caregiver Services Training Director Randolph Neil Conducted In-Service Training at Regency Park Oak Knoll Pasadena 4Health News:RSNA: Imaging Identifies Asymptomatic People at Risk for Stroke 2Health News:RSNA: Imaging Identifies Asymptomatic People at Risk for Stroke 3Health News:Researchers debunk myth about Parkinson's disease 2Health News:Zane Benefits Featured on Zions Bank Speaking on Business 2
... Oregon Health & Science University,s Vaccine and Gene Therapy Institute ... of infection before it becomes a rapidly replicating, ... the spread of the disease. The research is published in ... and will appear in a future printed edition. ...
... Bob Woodruff was injured while reporting in Iraq in 2006, ... his ability to recall and produce common words a ... language skills thanks to intensive behavioral therapy reading and ... for patients with aphasia has always been and will always ...
... Martek Biosciences Corporation (Nasdaq: MATK ) announced ... quarter of fiscal 2009 on March 4, 2009, at approximately ... 4:45 p.m. ET Martek will conduct a conference call to ... listen to the call live via webcast by visiting Martek,s ...
... but not available in U.S., was stopped early due ... -- A large study of tibolone, a drug used ... halted early after researchers found that the synthetic steroid ... survivors of the disease. , Tibolone isn,t available in ...
... Patient Check-In Company(TM), the leader in patient-intake, announced ... bringing total investment to date to $25 million. ... fund of the BlueCross BlueShield Association, and Sandbox ... Venture Partners, HLM Venture Partners, and Long River ...
... pathway that is responsible for generating excess connective tissue ... human patients with scleroderma. The study, published by Cell ... Developmental Cell , also reveals an intriguing but unexpected ... disease. , Platelet derived growth factors (PDGF) regulate ...
Cached Medicine News:Health News:OHSU vaccine research targets HIV in the slower, early stage of infection 2Health News:Exploring new pathways to language 2Health News:Menopause Drug Tied to Breast Cancer Recurrence 2Health News:Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries 2Health News:Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries 3Health News:Phreesia Secures $11.6M Series C Funding Led by BlueCross BlueShield Venture Partners and Sandbox Industries 4Health News:Tumor suppressor may attenuate fibrotic disease 2
(Date:9/15/2014)... YORK , Sept. 16, 2014 The ... Foundation (HNF) announced today an agreement to collaborate on ... and support the development of a stronger CMT patient ... financial support to several HNF,s initiatives including: ... in the HNF website featuring  HNF newsletters, materials and ...
(Date:9/15/2014)... , Sept. 16, 2014  Bayer HealthCare and ... Finland , have begun to ... ODM-201, an investigational oral androgen receptor inhibitor in ... in men with castration-resistant prostate cancer who have ... detectable metastases. The trial is designed to determine ...
(Date:9/15/2014)... , Sept. 15, 2014 /CNW/ - Health Minister Rona ... will make available for donation over $2.5 million in personal ... aid in the global response to the Ebola outbreak in ... WHO reported a shortage of equipment in the affected countries ... by front-line workers in the affected countries. ...
Breaking Medicine Technology:Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 2Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 3Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 2Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 3
... 28 Having hypertension, or high blood,pressure, reduces blood ... to a new study presented today at the annual ... "While hypertension is not a cause of Alzheimer,s disease, ... brain that increases its vulnerability,to the effects of the ...
... to ... total knee replacement, MINNEAPOLIS, ... of OrthoGlide Medial Knee Implant initial,clinical data., Data representing ... was presented on November 10th, 2007 at the,American College of ...
Cached Medicine Technology:High Blood Pressure May Heighten Effects of Alzheimer's Disease 2Clinical Data Presented on OrthoGlide(R) Medial Knee Implant 2
For the quantitative determination of Iron and IBC in serum. Colorimetric method utilizing ferrozine. Endpoint procedure measured at 560 nm. Linearity: 500 ug/dl....
HDL Cholesterol (PEG) Precip. Reagent + 5 ml of 50 mg/dl cholesterol std....
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...
... Intended for the quantitative ... plasma. Two vials, dry ... alphaketoglutarate. Uses NADPH to ... plasma compounds. Reaction: Enzymatic, ...
Medicine Products: